a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Multiple Myeloma · Neoplasm, Plasma Cell · Multiple Myeloma in Relapse
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
920th Hospital of Joint Logistics Support Force, Kunming, Yunnan, China
Contact: Principal Investigator (Sanbin Wang, MD)
Study leads
Sanbin Wang, MD
Principal Investigator
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Cheng Qian, PhD
Principal Investigator
Chongqing University Cancer Hospital